Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Diabetic Therapeutic industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Adocia
Sanofi
Arbutus Biopharma
Amarin
Bristol-Myers Squibb
Eli Lilly
AbbVie
Boehringer Ingelheim
Bionaturis
Actelion Pharmaceuticals
Astellas Pharma
Merck
Biodel
Atheronova
Biospherics
Arena Pharmaceuticals
Biosidus
Alnylam Pharmaceuticals
AstraZeneca
Akros Pharma
Aegerion Pharmaceuticals
BioMarin
By Type:
Gestational
Type 2
Type 1
By Application:
Insulin therapies
Non-insulin therapies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Diabetic Therapeutic Market Overview 2018-2029
-
1.1 China Diabetic Therapeutic Industry Development Overview
-
1.2 China Diabetic Therapeutic Industry Development History
-
1.3 China Diabetic Therapeutic Industry Market Size (2018-2029)
-
1.4 China Diabetic Therapeutic Market Analysis by Type from Production Side
-
1.4.1 China Diabetic Therapeutic Production Volume, Production Value and Growth Rate of Gestational (2018-2029)
-
1.4.2 China Diabetic Therapeutic Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
1.4.3 China Diabetic Therapeutic Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
1.5 China Diabetic Therapeutic Market Analysis by Application from Consumption End
-
1.5.1 China Diabetic Therapeutic Sales Volume, Sales Value and Growth Rate of Insulin therapies (2018-2029)
-
1.5.2 China Diabetic Therapeutic Sales Volume, Sales Value and Growth Rate of Non-insulin therapies (2018-2029)
-
1.6 China Diabetic Therapeutic Market Analysis by Region
-
1.6.1 North China Diabetic Therapeutic Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Diabetic Therapeutic Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Diabetic Therapeutic Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Diabetic Therapeutic Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Diabetic Therapeutic Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Diabetic Therapeutic Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Diabetic Therapeutic Market Size and Growth Rate from 2018-2029
Chapter 2 China Diabetic Therapeutic Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Diabetic Therapeutic Market Status and Competition at home and abroad in 2023
-
2.2.2 China Diabetic Therapeutic Market Status and Competition Analysis in 2023
-
2.2.3 China Diabetic Therapeutic Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Diabetic Therapeutic Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Diabetic Therapeutic Industry Development
Chapter 3 Diabetic TherapeuticIndustry Chain Analysis
-
3.1 Diabetic Therapeutic Industry Chain
-
3.2 Diabetic Therapeutic Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Diabetic Therapeutic Market
-
3.3 Diabetic Therapeutic Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Diabetic Therapeutic Market
Chapter 4 China Diabetic Therapeutic Market, by Type
-
4.1 China Diabetic Therapeutic Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Diabetic Therapeutic Total Production Volume and Growth Rate from Production Side
-
4.5 China Diabetic Therapeutic Production Volume and Growth Rate, by Type
-
4.5.1 China Diabetic Therapeutic Production Volume and Growth Rate of Gestational
-
4.5.2 China Diabetic Therapeutic Production Volume and Growth Rate of Type 2
-
4.5.3 China Diabetic Therapeutic Production Volume and Growth Rate of Type 1
Chapter 5 China Diabetic Therapeutic Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Diabetic Therapeutic Total Market Size and Growth Rate from Consumption End
-
5.5 China Diabetic Therapeutic Market Size and Growth Rate, by Application
-
5.5.1 China Diabetic Therapeutic Market Size and Growth Rate of Insulin therapies
-
5.5.2 China Diabetic Therapeutic Market Size and Growth Rate of Non-insulin therapies
Chapter 6 China Diabetic Therapeutic Market, by Region
-
6.1 China Diabetic Therapeutic Production Volume and Production Value, by Region
-
6.2 China Diabetic Therapeutic Sales Volume and Sales Value, by Region
Chapter 7 North China Diabetic Therapeutic Market Analysis
-
7.1 North China Diabetic Therapeutic Market, by Type
-
7.2 North China Diabetic Therapeutic Market, by Application
Chapter 8 Central China Diabetic Therapeutic Market Analysis
-
8.1 Central China Diabetic Therapeutic Market, by Type
-
8.2 Central China Diabetic Therapeutic Market, by Application
Chapter 9 South China Diabetic Therapeutic Market Analysis
-
9.1 South China Diabetic Therapeutic Market, by Type
-
9.2 South China Diabetic Therapeutic Market, by Application
Chapter 10 East China Diabetic Therapeutic Market Analysis
-
10.1 East China Diabetic Therapeutic Market, by Type
-
10.2 East China Diabetic Therapeutic Market, by Application
Chapter 11 Northeast China Diabetic Therapeutic Market Analysis
-
11.1 Northeast China Diabetic Therapeutic Market, by Type
-
11.2 Northeast China Diabetic Therapeutic Market, by Application
Chapter 12 Southwest China Diabetic Therapeutic Market Analysis
-
12.1 Southwest China Diabetic Therapeutic Market, by Type
-
12.2 Southwest China Diabetic Therapeutic Market, by Application
Chapter 13 Northwest China Diabetic Therapeutic Market Analysis
-
13.1 Northwest China Diabetic Therapeutic Market, by Type
-
13.2 Northwest China Diabetic Therapeutic Market, by Application
Chapter 14 Company Profiles
-
14.1 Adocia
-
14.1.1 Adocia Company Profile
-
14.1.2 Adocia Diabetic Therapeutic Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Sanofi
-
14.2.1 Sanofi Company Profile
-
14.2.2 Sanofi Diabetic Therapeutic Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Arbutus Biopharma
-
14.3.1 Arbutus Biopharma Company Profile
-
14.3.2 Arbutus Biopharma Diabetic Therapeutic Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Amarin
-
14.4.1 Amarin Company Profile
-
14.4.2 Amarin Diabetic Therapeutic Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Bristol-Myers Squibb
-
14.5.1 Bristol-Myers Squibb Company Profile
-
14.5.2 Bristol-Myers Squibb Diabetic Therapeutic Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Eli Lilly
-
14.6.1 Eli Lilly Company Profile
-
14.6.2 Eli Lilly Diabetic Therapeutic Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 AbbVie
-
14.7.1 AbbVie Company Profile
-
14.7.2 AbbVie Diabetic Therapeutic Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Boehringer Ingelheim
-
14.8.1 Boehringer Ingelheim Company Profile
-
14.8.2 Boehringer Ingelheim Diabetic Therapeutic Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Bionaturis
-
14.9.1 Bionaturis Company Profile
-
14.9.2 Bionaturis Diabetic Therapeutic Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Actelion Pharmaceuticals
-
14.10.1 Actelion Pharmaceuticals Company Profile
-
14.10.2 Actelion Pharmaceuticals Diabetic Therapeutic Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Astellas Pharma
-
14.11.1 Astellas Pharma Company Profile
-
14.11.2 Astellas Pharma Diabetic Therapeutic Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Merck
-
14.12.1 Merck Company Profile
-
14.12.2 Merck Diabetic Therapeutic Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Biodel
-
14.13.1 Biodel Company Profile
-
14.13.2 Biodel Diabetic Therapeutic Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Atheronova
-
14.14.1 Atheronova Company Profile
-
14.14.2 Atheronova Diabetic Therapeutic Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Biospherics
-
14.15.1 Biospherics Company Profile
-
14.15.2 Biospherics Diabetic Therapeutic Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Arena Pharmaceuticals
-
14.16.1 Arena Pharmaceuticals Company Profile
-
14.16.2 Arena Pharmaceuticals Diabetic Therapeutic Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Biosidus
-
14.17.1 Biosidus Company Profile
-
14.17.2 Biosidus Diabetic Therapeutic Market Performance
-
14.17.3 Product&Service Introduction
-
14.18 Alnylam Pharmaceuticals
-
14.18.1 Alnylam Pharmaceuticals Company Profile
-
14.18.2 Alnylam Pharmaceuticals Diabetic Therapeutic Market Performance
-
14.18.3 Product&Service Introduction
-
14.19 AstraZeneca
-
14.19.1 AstraZeneca Company Profile
-
14.19.2 AstraZeneca Diabetic Therapeutic Market Performance
-
14.19.3 Product&Service Introduction
-
14.20 Akros Pharma
-
14.20.1 Akros Pharma Company Profile
-
14.20.2 Akros Pharma Diabetic Therapeutic Market Performance
-
14.20.3 Product&Service Introduction
-
14.21 Aegerion Pharmaceuticals
-
14.21.1 Aegerion Pharmaceuticals Company Profile
-
14.21.2 Aegerion Pharmaceuticals Diabetic Therapeutic Market Performance
-
14.21.3 Product&Service Introduction
-
14.22 BioMarin
-
14.22.1 BioMarin Company Profile
-
14.22.2 BioMarin Diabetic Therapeutic Market Performance
-
14.22.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Diabetic Therapeutic Industry Research Conclusions
-
15.2 Diabetic Therapeutic Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Diabetic Therapeutic Industry Market Size (2018-2029)
-
Figure China Diabetic Therapeutic Production Volume, Production Value and Growth Rate of Gestational (2018-2029)
-
Figure China Diabetic Therapeutic Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
Figure China Diabetic Therapeutic Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
Figure China Diabetic Therapeutic Sales Volume, Sales Value and Growth Rate of Insulin therapies (2018-2029)
-
Figure China Diabetic Therapeutic Sales Volume, Sales Value and Growth Rate of Non-insulin therapies (2018-2029)
-
Figure North China Diabetic Therapeutic Market Size and Growth Rate from 2018-2029
-
Figure Central China Diabetic Therapeutic Market Size and Growth Rate from 2018-2029
-
Figure South China Diabetic Therapeutic Market Size and Growth Rate from 2018-2029
-
Figure East China Diabetic Therapeutic Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Diabetic Therapeutic Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Diabetic Therapeutic Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Diabetic Therapeutic Market Size and Growth Rate from 2018-2029
-
Figure Diabetic Therapeutic Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Diabetic Therapeutic Market Share by Type in 2018
-
Figure China Diabetic Therapeutic Market Share by Type in 2023
-
Figure China Diabetic Therapeutic Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Diabetic Therapeutic Production Volume and Growth Rate of Gestational (2018-2023)
-
Figure China Diabetic Therapeutic Production Volume and Growth Rate of Type 2 (2018-2023)
-
Figure China Diabetic Therapeutic Production Volume and Growth Rate of Type 1 (2018-2023)
-
Figure China Diabetic Therapeutic Market Share by Application in 2018
-
Figure China Diabetic Therapeutic Market Share by Application in 2023
-
Figure China Diabetic Therapeutic Total Market Size and Growth Rate from Consumption End
-
Figure China Diabetic Therapeutic Market Size and Growth Rate of Insulin therapies (2018-2023)
-
Figure China Diabetic Therapeutic Market Size and Growth Rate of Non-insulin therapies (2018-2023)
-
Table China Diabetic Therapeutic Production Volume by Region (2018-2023)
-
Table China Diabetic Therapeutic Production Volume Share by Region (2018-2023)
-
Figure China Diabetic Therapeutic Production Volume Share by Region (2018-2023)
-
Table China Diabetic Therapeutic Production Value by Region (2018-2023)
-
Table China Diabetic Therapeutic Production Value Share by Region (2018-2023)
-
Figure China Diabetic Therapeutic Production Value Share by Region (2018-2023)
-
Table China Diabetic Therapeutic Sales Volume by Region (2018-2023)
-
Table China Diabetic Therapeutic Sales Volume Share by Region (2018-2023)
-
Figure China Diabetic Therapeutic Sales Volume Share by Region (2018-2023)
-
Table China Diabetic Therapeutic Sales Value by Region (2018-2023)
-
Table China Diabetic Therapeutic Sales Value Share by Region (2018-2023)
-
Figure China Diabetic Therapeutic Sales Value Share by Region (2018-2023)
-
Table North China Diabetic Therapeutic Production Volume by Type (2018-2023)
-
Table North China Diabetic Therapeutic Production Volume Share by Type (2018-2023)
-
Figure North China Diabetic Therapeutic Production Volume Share by Type (2018-2023)
-
Table North China Diabetic Therapeutic Sales Volume by Application (2018-2023)
-
Table North China Diabetic Therapeutic Sales Volume Share by Application (2018-2023)
-
Figure North China Diabetic Therapeutic Sales Volume Share by Application (2018-2023)
-
Table Central China Diabetic Therapeutic Production Volume by Type (2018-2023)
-
Table Central China Diabetic Therapeutic Production Volume Share by Type (2018-2023)
-
Figure Central China Diabetic Therapeutic Production Volume Share by Type (2018-2023)
-
Table Central China Diabetic Therapeutic Sales Volume by Application (2018-2023)
-
Table Central China Diabetic Therapeutic Sales Volume Share by Application (2018-2023)
-
Figure Central China Diabetic Therapeutic Sales Volume Share by Application (2018-2023)
-
Table South China Diabetic Therapeutic Production Volume by Type (2018-2023)
-
Table South China Diabetic Therapeutic Production Volume Share by Type (2018-2023)
-
Figure South China Diabetic Therapeutic Production Volume Share by Type (2018-2023)
-
Table South China Diabetic Therapeutic Sales Volume by Application (2018-2023)
-
Table South China Diabetic Therapeutic Sales Volume Share by Application (2018-2023)
-
Figure South China Diabetic Therapeutic Sales Volume Share by Application (2018-2023)
-
Table East China Diabetic Therapeutic Production Volume by Type (2018-2023)
-
Table East China Diabetic Therapeutic Production Volume Share by Type (2018-2023)
-
Figure East China Diabetic Therapeutic Production Volume Share by Type (2018-2023)
-
Table East China Diabetic Therapeutic Sales Volume by Application (2018-2023)
-
Table East China Diabetic Therapeutic Sales Volume Share by Application (2018-2023)
-
Figure East China Diabetic Therapeutic Sales Volume Share by Application (2018-2023)
-
Table Northeast China Diabetic Therapeutic Production Volume by Type (2018-2023)
-
Table Northeast China Diabetic Therapeutic Production Volume Share by Type (2018-2023)
-
Figure Northeast China Diabetic Therapeutic Production Volume Share by Type (2018-2023)
-
Table Northeast China Diabetic Therapeutic Sales Volume by Application (2018-2023)
-
Table Northeast China Diabetic Therapeutic Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Diabetic Therapeutic Sales Volume Share by Application (2018-2023)
-
Table Southwest China Diabetic Therapeutic Production Volume by Type (2018-2023)
-
Table Southwest China Diabetic Therapeutic Production Volume Share by Type (2018-2023)
-
Figure Southwest China Diabetic Therapeutic Production Volume Share by Type (2018-2023)
-
Table Southwest China Diabetic Therapeutic Sales Volume by Application (2018-2023)
-
Table Southwest China Diabetic Therapeutic Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Diabetic Therapeutic Sales Volume Share by Application (2018-2023)
-
Table Northwest China Diabetic Therapeutic Production Volume by Type (2018-2023)
-
Table Northwest China Diabetic Therapeutic Production Volume Share by Type (2018-2023)
-
Figure Northwest China Diabetic Therapeutic Production Volume Share by Type (2018-2023)
-
Table Northwest China Diabetic Therapeutic Sales Volume by Application (2018-2023)
-
Table Northwest China Diabetic Therapeutic Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Diabetic Therapeutic Sales Volume Share by Application (2018-2023)
-
Table Adocia Company Profile
-
Table Adocia Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Arbutus Biopharma Company Profile
-
Table Arbutus Biopharma Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Amarin Company Profile
-
Table Amarin Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Profile
-
Table Bristol-Myers Squibb Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table AbbVie Company Profile
-
Table AbbVie Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Company Profile
-
Table Boehringer Ingelheim Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Bionaturis Company Profile
-
Table Bionaturis Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Actelion Pharmaceuticals Company Profile
-
Table Actelion Pharmaceuticals Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Astellas Pharma Company Profile
-
Table Astellas Pharma Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Biodel Company Profile
-
Table Biodel Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Atheronova Company Profile
-
Table Atheronova Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Biospherics Company Profile
-
Table Biospherics Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Arena Pharmaceuticals Company Profile
-
Table Arena Pharmaceuticals Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Biosidus Company Profile
-
Table Biosidus Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Alnylam Pharmaceuticals Company Profile
-
Table Alnylam Pharmaceuticals Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Akros Pharma Company Profile
-
Table Akros Pharma Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table Aegerion Pharmaceuticals Company Profile
-
Table Aegerion Pharmaceuticals Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
Table BioMarin Company Profile
-
Table BioMarin Diabetic Therapeutic Revenue, Price and Gross (2018-2023)
-
